Biotechnology Jobs

• London
• Hybrid · 2–3 days in office
• Senior

Sits within GSK's Chemical Manufacturing & Control function, shaping how AI transforms manufacturing sites worldwide. Runs day-to-day tech transfer engagement with sites and CMOs, sizes AI opportunities, defines target process, data and agent architecture, and drives agentification and recipe building for new products alongside forward deployed engineering pods.

MES · LIMS · ERP +6

• Stevenage
• Hybrid · 2–3 days in office
• Senior

Sits within GSK's Chemical Manufacturing & Control function, running day-to-day tech transfer engagement with manufacturing sites and CMOs while redesigning processes in detail. Shapes NPI launch strategy covering site impact assessment, capacity management, digital twins, scenario planning and virtual line commissioning, and defines the target process, data and agent architecture. Owns the tech transfer package and drives agentification and MES-ready recipe building alongside forward deployed engineering pods.

MES · LIMS · ERP +6

• Maidenhead
• Hybrid · 3 days in office
• Director

Leads strategic sourcing and evaluation of late-stage external clinical assets in Immunology, from Phase 2 through marketed drugs, as the senior S&E leader within the Therapy Area Leadership Team. Drives proactive sourcing, cross-functional due diligence, and KOL engagement, partnering with BD to advance high-priority opportunities through negotiation and deal close.

• London
• Hybrid · 3 days in office
• Lead

Lead formulation strategy for small molecules across drug discovery and preclinical development, designing technologies such as solid dispersions and co-crystals to improve solubility, stability and manufacturability. Work within an interdisciplinary team alongside AI/ML drug design platform groups, managing external CRO resources and authoring regulatory submissions.

ASAP

• London
• Hybrid · 3 days in office
• Senior

Lead pharmacology and translational biology strategy for large molecule therapeutics, designing in vivo efficacy and complex in vitro functional assays. Act as Biology Lead on projects, coordinating internal workflows and external CROs, and collaborate with ML and computational biology teams to feed data into generative AI design loops.

AI · ML · Generative AI +1

• Abingdon
• On-site
• Director · manages people
• Permanent

Owns Evotec's in silico therapeutics design capability, uniting computational chemistry, generative and modality design (small molecules, peptides, protein engineering, degraders, molecular glues) and predictive ADMET/safety under one mandate. A newly created unit within the In Silico & AI group with an explicit build mandate: set technical vision, grow a multi-site team, and industrialise repeatable, benchmarked methods across partner programmes.

RDKit · Python · AlphaFold

• Abingdon
• Director · manages people
• Permanent

Leads Evotec's consolidated AI Accelerator, owning machine learning, generative and agentic AI, and therapeutic hypothesis groups. Sets the AI vision and roadmap, makes build/buy/partner decisions for the AI stack, and turns proprietary multi-omics and experimental data into predictive models and reusable IP. Acts as the senior external technical voice for AI in drug discovery.

• Maidenhead
• Mid-level

Oversees vendor delivery of medical evaluations for individual case safety reports, applying medical and scientific judgment on causality, expectedness and seriousness. Trains Medical Evaluators, sets assessment frameworks and drives process improvements across Global Safety and Pharmacovigilance. Requires deep pharmacovigilance knowledge and cross-functional stakeholder work.

• London
• Hybrid
• Senior

Plans and executes medical and scientific engagement activities such as advisory boards, congress symposia, external expert engagements and medical education programmes across oncology, cardiovascular, renal, neuroscience and immunology. Works within the International Medical Affairs Center of Excellence, translating engagement strategy into operational plans, managing vendors, logistics and budgets, and reinforcing compliant, audit-ready ways of working.

CRM Software

• Uxbridge
• Hybrid
• Director

Leads EU regulatory strategy for an immunology and cardiovascular portfolio, from early development through registration and lifecycle management. Acts as the regulatory lead for assigned development teams, negotiating with the EMA and other health authorities and building integrated submission plans. Integrates scientific, medical, legal and business perspectives while monitoring European regulatory trends.

EMA

• London
• Hybrid
• Director · manages people

Leads global medical strategy for the Neurosciences portfolio, primarily Dysport Movement Disorders indications, defining evidence generation plans, registries and investigator-sponsored research. Acts as Medical functional lead on the global Asset Team, chairs the Medical & Evidence Generation Team, and represents Ipsen with KOLs, societies and advocacy groups. Also leads, coaches and develops Global Medical Directors across the organisation.

Dysport

• London
• Hybrid
• Lead · manages people

Leads one or more Early Development Asset Teams, owning integrated strategy from candidate nomination through first-in-human trials across preclinical, translational, clinical, regulatory and CMC workstreams. Serves as scientific champion for oncology assets, presenting data and investment recommendations to governance bodies and contributing to in-licensing due diligence.

• Uxbridge
• Hybrid
• Director

Serves as scientific authority for clinical studies across an assigned asset or indication, from protocol development through CSR review and regulatory submission. Leads clinical oversight of study data with Data Management and Programming, may act as Trial Lead on complex global studies, and presents to investigators, KOLs and senior leadership. Also supports process improvement, training and mentoring within the Clinical Capabilities function.